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Abstract  
There are a few children with isolated congenital complete atrioventricular block (ICCAVB) who do 
not require a pacemaker. We report a female infant born at 36 weeks by emergency cesarean sec-
tion because of fetal heart rate abnormalities who was diagnosed as having ICCAVB. In accordance 
with the echocardiographic findings, we simultaneously measured the cardiothoracic ratio (CTR) by 
chest radiography and serum N-terminal pro-BNP (NT-proBNP) and have continued to follow her 
as an outpatient for about 8 years. CTR and NT-proBNP showed strong positive correlation 
(r=0.894, p<0.05). In such few children with ICCAVB as this patient, CTR measurement during 
their follow-up would be very useful to easily understand their cardiac load status. 
Key words : cardiothoracic ratio, congenital complete atrioventricular block, follow up, heart fail-
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Introduction
The cardiac ventricles are the main site of brain 
natriuretic peptide (BNP) synthesis, and they release 
it in response to volume (increased wall stress) or 
pressure (ventricular filling pressure) loading1). 
ProBNP, the inactive precursor, is cleaved into BNP, 
the active component, and N-terminal pro-BNP 
(NT-proBNP), an inactive by-product. Plasma con-
centrations of BNP correspond well with echocardio-
graphic findings of ventricular strain2). Plasma NT-
proBNP is very high during the first few days of life 
in healthy neonates, decreases rapidly until the end 
of the first week of life, and then decreases slowly 
until the end of the neonatal period3-5). Among pa-
tients with bradyarrhythmia, there are few reports of 
plasma NT-proBNP increasing in proportion to the 
aggravation of atrioventricular asynchrony6-8). Con-
genital complete atrioventricular block (CCAVB) oc-
curs in one out of 14,000 to 20,000 live births, most 
commonly after damage to the normal structure of 
the fetal heart by maternal autoantibodies against ri-
bonucleoproteins (anti-Ro/SSA, anti-La/SSB)9). Al-
though the characteristics of fetal and maternal anti-
body-associated AVB have largely been clarified, the 
clinical course of isolated, non-immune AVB (IC-
CAVB) diagnosed in utero, at birth or thereafter re-
mains obscure10).
To our knowledge, there are no reports on the 
natural course of ICCAVB accompanied by serial 
changes of plasma NT-proBNP. We present a female 
preterm infant with ICCAVB in whom changes of 
plasma NT-proBNP were measured serially along 
with the cardiothoracic ratio (CTR) soon after 
birth11,12). This is the first report on combined use of 
CTR and NT-proBNP in the follow-up of ICCAVB.
Case Report
The healthy, asymptomatic 30-year-old mother 
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was referred to a domestic gynecological clinic at 36 
weeks of gestation for a regular pregnancy check. 
Fetal echocardiography revealed a structurally nor-
mal heart with a ventricular rate of 65-70 beats/min 
and no pericardial effusion. A female baby (weight, 
2,300 g ; length, 46.0 cm) was born by emergency 
cesarean section on the same day after the diagnosis 
of fetal distress. Electrocardiography reveled 
CCAVB with an atrial rate 150 beats/min and ven-
tricular rate of 70-75 beats/min. Laboratory blood 
examinations of mother and baby were negative for 
antinuclear antibody. The baby was transferred to 
our NICU for evaluation of her arrhythmia and treat-
ment. As a late preterm infant, she showed only 
mild respiratory distress and no signs of heart fail-
ure, and oral feeding progressed smoothly. She 
was ultimately discharged on day 62 with no serious 
complications (weight, 3,111 g ; length, 52.1 
cm). This girl has remained in CAVB with an atrial 
rate 115-125 beats/min and a ventricular rate of 50-
55 beats/min up to the time of her last examination 
at the age of 8 years (Fig. 1). She has never com-
plained of inconvenience in her elementary school 
life and participates in physical education classes as 
much as she can13). Written informed consent was 
obtained from the patient’s parents to publish this 
case report.
In accordance with her echocardiographic find-
ings, the transition of her CTR by chest radiography 
and serum NT-proBNP by blood examination has 
been followed from birth to her current age of 8 
years. Her serum NT-proBNP was 6,285 pg/mL at 
birth but had sharply increased to a maximum of 
45,146 pg/mL at 1 month of age. It then decreased, 
but not to within the reference interval, and its value 
has remained high at each measurement3,4). Thus-
far, it has been observed at four time points that her 
CTR has characteristically increased once and then 
decreased : from the age of 8 months to 10 months, 
around 2 years old, from 3 to 5 years old, and from 6 
to 7 years old. NT-proBNP also showed a trend al-
most parallel to that of CTR (Fig. 2a). As a result, 
it was confirmed that the two had a strong positive 
correlation (r=0.894, p<0.05) (Fig. 2b). 
Discussion
To the best of our knowledge, studies of NT-
proBNP in neonatal diseases have been reported as 
the serial changes of NT-proBNP in the pathologies 
of respiratory distress syndrome14), transient tachy-
pnea of the newborn15,16), persistent ductus arterio-
sus2,17), persistent pulmonary hypertension18,19), 
bronchopulmonary dysplasia20,21) and asphyxia22). 
However, our patient had none of these diseases. 
The marked increase and subsequent decrease of 
NT-proBNP in the early postnatal period was con-
sidered to be due solely to her bradyarrhythmia. 
As a result, it has been possible to diagnose the sta-
tus of this patient’s cardiac load induced by the IC-
CAVB on the basis of the temporal transition of NT-
proBNP from the early postnatal age to her present 
age of 8 years.
Plasma NT-proBNP as a biochemical indicator 
and CTR as a physiological indicator were simulta-
neously measured, and their serial changes were fol-
lowed to evaluate the degree of volume loading of 
the heart due to ICCAVB from the early postnatal 
period to the present6-8). NT-proBNP was mea-
sured by electrochemiluminescence immunoassay 
and evaluated on a logarithmic scale. As a result, a 
strong positive correlation between these two fac-
tors was revealed throughout the observation peri-
od. Stroke volume in patients who develop solitary 
CCAVB will increase to compensate for a low heart 
rate. Volume loading of the left ventricle can occur 
in these patients, followed by heart failure, when the 
Fig. 1. Electrocardiogram at 8 years of age.
 This electrocardiogram shows complete atrioven-
tricular block with a ventricular rate of 50 beats/
min and an atrial rate of 129 beats/min.
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heart can no longer bear the volume load. Echocar-
diographic parameters such as left ventricular dia-
stolic internal diameter and end-systolic wall stress 
are better physiological indicators, but they must be 
evaluated in comparison with reference intervals 
from healthy children23) because they gradually in-
crease year by year. In contrast, CTR is a physical 
ratio unique to each child and has the advantage of 
being easy to evaluate. As one of the most basic 
and standard examinations, CTR on chest X-ray has 
been used as an index of cardiac enlargement. Un-
like NT-proBNP, CTR is not influenced by renal 
function1). CTR increases with cardiac hypertro-
phy, but it can also be influenced by other factors 
such as extracellular volume and pulmonary diseas-
es such as pulmonary hypertension11,12).
At the aforementioned four periods, the transi-
tion of this patient’s CTR showed a temporary in-
crease and decrease. NT-proBNP also tended to 
show similar changes paralleling the changes in 
CTR. As a result, CTR and NT-proBNP have 
shown a strong positive correlation throughout the 8 
years since her birth. Babies begin to stand from 
crawling at 8 to 10 months, and the movement from 
walking to a bit of running is complete at around 2 
years old. Children attend kindergarten at age 3 to 
5, at which point they leave the family and increase 
their amount of exercise through varied play with 
other young children in their age group. After en-
tering elementary school at 6 to 7 years old, they in-
crease their amount of exercise even further. What 
is common to each of these periods is that each is a 
time of progression in which children need to exceed 
their previous amount of exercise and adapt to 
it. Our patient’s parents frequently described these 
changes in living conditions at regular outpatient 
visits, and as a result, we confirmed that our patient 
could adapt to the amount of exercise required at 
each new period in her life.
This patient has had no other complications of 
cardiovascular disease, so her CTR has been influ-
enced only by volume loading due to bradyarrhyth-
mia. Although a few children with ICCAVB like her 
also do not require a pacemaker, CTR measurement 
during their follow-up would be very useful to easily 
understand their cardiac load status. 
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(a)
(b)
Fig. 2. NT-proBNP levels and cardiothoracic ratio 
(CTR) from birth to 8 years.
 (a) ◦ and ◦ indicate plasma NT-proBNP levels 
and CTR, respectively. The serial changes of 
NT-proBNP and CTR were similar to those of 
healthy children, but the plasma NT-proBNP lev-
els in our patient were always remarkably high.    
The small figure in the upper right shows the tran-
sition between the two in the early neonatal peri-
od. The concentration of NT-proBNP was con-
siderably increased until one month after birth.    
The CTR also gradually increased in parallel, and 
both decreased thereafter.
 (b) A significant correlation with a coefficient of 
0.894 (p<0.05) was observed in the regression 
equation obtained by the least squares method be-
tween the plasma NT-proBNP levels and CTRs.    
We evaluated these data with on a logarithmic 
scale.
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